Nanoplasmonic multiplex biosensing for COVID-19 vaccines
The ongoing emergence of severe acute respiratory syndrome caused by the new coronavirus (SARS-CoV-2) variants requires swift actions in identifying specific antigens and optimizing vaccine development to maximize the humoral response of the patient. Measuring the specificity and the amount of antib...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier Ltd
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |